Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Operating Leases (2022 - 2025)

LifeStance Health (LFST) has disclosed Operating Leases for 4 consecutive years, with $148.6 million as the latest value for Q4 2025.

  • Quarterly Operating Leases changed 0.1% to $148.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $148.6 million through Dec 2025, changed 0.1% year-over-year, with the annual reading at $148.6 million for FY2025, 0.1% changed from the prior year.
  • Operating Leases for Q4 2025 was $148.6 million at LifeStance Health, up from $144.2 million in the prior quarter.
  • The five-year high for Operating Leases was $212.6 million in Q4 2022, with the low at $143.4 million in Q2 2025.
  • Average Operating Leases over 4 years is $171.6 million, with a median of $165.8 million recorded in 2024.
  • The sharpest move saw Operating Leases fell 19.38% in 2024, then decreased 0.1% in 2025.
  • Over 4 years, Operating Leases stood at $212.6 million in 2022, then fell by 14.69% to $181.4 million in 2023, then fell by 18.01% to $148.7 million in 2024, then dropped by 0.1% to $148.6 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $148.6 million, $144.2 million, and $143.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.